Alper Erdoğan is an Executive Medical Director at Eli Lilly and Company, with a strong background in global oncology and neurology. Previously, Alper served as a Senior Medical Director and held various leadership positions, including Medical Advisor for Immunology and Medical Lead for multiple regions. Alper's earlier experience includes roles at Roche, where they managed neuroscience and oncology projects, and worked as a physician at the Turkish Ministry of Health. Alper earned a Doctor of Medicine from Uludağ Üniversitesi and a Master of Science in Health Economics and Pharmacoeconomics from Hacettepe Üniversitesi.
This person is not in the org chart
This person is not in any teams
This person is not in any offices